Letters to the EditorLETTER TO THE EDITOR Response to “Tocilizumab therapy and COVID-19” Pallavi Bhargava, MD Notes and Affiliations Notes and Affiliations Received: August 24, 2021 Accepted: August 24, 2021 Published: September 8, 2021 Pallavi Bhargava, MD, Division of Infectious Disease, Department of Internal Medicine, Henry Ford Health System, 2799 West Grand Blvd, Detroit, MI 48202, USA J Osteopath Med; 121(11): 867-868 https://doi.org/10.1515/jom-2021-0212